Elevance Health, Inc.
ELV
Abajo encontrarás el precio en vivo de Elevance Health, Inc. (ELV), un gráfico de 1 año, 8 indicadores (RSI, MACD, Bollinger, MA, EMA, Stochastic, ATR, Volumen) y el modo de comparación. Puedes añadir a tu cartera, marcar como favorito o configurar alertas de precio.
Elevance Health, Inc. (ELV) es una empresa de Healthcare con sede en United States. Opera en Healthcare Plans y emplea aproximadamente a 96,129 personas. En el último año ELV osciló entre 273.71 y 436.24 USD. El P/E TTM ronda 16.5 sobre una capitalización de unos 80.92B USD. Actualmente ofrece una rentabilidad por dividendo del 1.84%.
- Prev close
- $372.85
- Volume (24h)
- $716.45M
- Market cap
- $80.92B
- Currency
- USD
Puntuación
52/ 100 · Mixto
- Valor72
- Calidad35
- Momento57
- Crecimiento24
- Riesgo78
- Dividendo57
- Liquidez44
Compuesto de datos de mercado públicos. Solo informativo — no es asesoramiento de inversión.
Proyección de tendencia
Hacia dónde apunta la tendencia reciente si continúa.
- +5 barras
- 375.9831 +0.77%
- +20 barras
- 379.9838 +1.84%
- +60 barras
- 381.5429 +2.26%
- +120 barras
- 381.6002 +2.28%
Continuación de regresión lineal — no es una predicción ni asesoramiento de inversión. ±1σ ≈ 68% · ±2σ ≈ 95%: ±0.0405 USD.
Interpretación
Las señales compuestas parecen mixtas. Fortaleza: perfil de riesgo con debilidad: crecimiento. El precio está en la mitad del rango reciente, la tendencia es ascendente.
Observación descriptiva — no es asesoramiento de inversión.
Desglose de la puntuación
Los valores brutos detrás de cada pilar para que veas qué está leyendo el compuesto.
- Valor72/100
Valor parece sólido — impulsado por P/E (16.5).
P/E:16.5P/B:1.81PEG:1.32 - Calidad35/100
Calidad parece débil — impulsado por Margen bruto (25.99%).
ROE:11.13%ROA:3.83%Margen neto:2.47%Margen bruto:25.99% - Momento57/100
Momento parece mixto — impulsado por Cambio 52 sem (34.96%).
Cambio 52 sem:34.96% - Crecimiento24/100
Crecimiento parece frágil — impulsado por Crecimiento BPA (-13.10%).
Crecimiento ingresos:1.40%Crecimiento BPA:-13.10% - Riesgo78/100
Riesgo parece fuerte — impulsado por Deuda / capital (68.95).
Beta:0.68Deuda / capital:68.95Interés corto:3.10% - Dividendo57/100
Dividendo parece mixto — impulsado por Tasa de reparto (30.34%).
Rentabilidad dividendo:1.84%Tasa de reparto:30.34% - Liquidez44/100
Liquidez parece débil — impulsado por Ratio corriente (1.52).
Ratio corriente:1.52Prueba ácida:1.37
Derivado de datos de mercado públicos — informativo, no es asesoramiento de inversión.
Niveles de referencia
Retrocesos y extensiones de Fibonacci sobre el rango reciente.
Solo referencia — no es asesoramiento de inversión.
Estas coordenadas describen agrupamientos pasados, no dónde comprar o vender. Investiga por tu cuenta antes de operar.
- ResistenciaExtensión Fib +161.8%615.5467 USD+64.98% del actual
- ResistenciaExtensión Fib +100%547.06 USD+46.62% del actual
- ResistenciaExtensión Fib +61.8%504.7267 USD+35.28% del actual
- ResistenciaExtensión Fib +27.2%466.383 USD+25.00% del actual
- ResistenciaRetroceso Fib 23.6%410.0865 USD+9.91% del actual
- ResistenciaRetroceso Fib 38.2%393.9068 USD+5.57% del actual
- ResistenciaPunto medio Fib 50%380.83 USD+2.07% del actual
- Actual373.11 USD
- SoporteRetroceso Fib 61.8%367.7532 USD-1.44% del actual
- SoporteRetroceso Fib 78.6%349.1355 USD-6.43% del actual
- SoporteExtensión Fib −27.2%295.277 USD-20.86% del actual
- SoporteExtensión Fib −61.8%256.9333 USD-31.14% del actual
- SoporteExtensión Fib −100%214.6 USD-42.48% del actual
Financials
- 52w high
- $436.24
- 52w low
- $273.71
- 52w change
- 34.96%
- Day high
- $377.76
- Day low
- $365.38
- P/E (TTM)
- 16.5
- Forward P/E
- 12.58
- PEG
- 1.32
- Price / Book
- 1.81
- Beta (5Y)
- 0.68
- Enterprise value
- 74.59B
- EV / Revenue
- 0.37
- EV / EBITDA
- 8.96
- EPS (TTM)
- $22.61
- Forward EPS
- $29.65
- Dividend yield
- 1.84%
- Dividend rate
- $6.88
- Payout ratio
- 30.34%
- Revenue (TTM)
- 201.11B
- EBITDA
- 8.32B
- Free cash flow
- 4.31B
- Total cash
- 37.51B
- Total debt
- 31.04B
- Debt / Equity
- 68.95
- Current ratio
- 1.52
- Quick ratio
- 1.37
- Profit margin
- 2.47%
- Gross margin
- 25.99%
- Return on assets
- 3.83%
- Return on equity
- 11.13%
- Shares outstanding
- 216.87M
- Float
- 216.41M
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.
Analyst & Risk
- Beta (vs S&P 500)
- 0.68
- less volatile
- 52-week change
- 34.96%
- Short % of float
- 3.10%
- Short ratio (days)
- 3.32
- Debt / Equity
- 68.95
- very high leverage
- Current ratio
- 1.52
- Quick ratio
- 1.37
- ROE
- 11.13%
- ROA
- 3.83%
- PEG ratio
- 1.32
- fair
- EV / Revenue
- 0.37
- EV / EBITDA
- 8.96
- Revenue growth
- 1.40%
- Earnings growth
- -13.10%
- EBITDA
- 8.32B
- Free cash flow
- 4.31B
- Total cash
- 37.51B
- Total debt
- 31.04B
- Insider holdings
- 0.18%
- Institutional
- 93.54%
Recent rating changes
- 2026-07-17Leerink PartnersMarket Perform → Market Performmain
- 2026-07-16RBC CapitalSector Perform → Sector Performmain
- 2026-07-16Wells FargoOverweight → Overweightmain
- 2026-07-16GuggenheimBuy → Buymain
- 2026-07-16BarclaysOverweight → Overweightmain
- 2026-07-16BairdNeutral → Neutralmain
- 2026-07-14TD CowenBuy → Buymain
- 2026-07-14Truist SecuritiesBuy → Buymain
Financial documents
- Periodic Financial Reports10-Q2026-07-15
- Annual report of employee stock purchase11-K2026-06-17
- Corporate Changes & Voting Matters8-K2026-06-10
- Corporate Changes & Voting Matters8-K2026-05-13
- Corporate Changes & Voting Matters8-K2026-04-22
- Proxy StatementsDEFA14A2026-03-27
- Corporate Changes & Voting Matters8-K2026-03-10
- Corporate Changes & Voting Matters8-K2026-03-02
- Corporate Changes & Voting Matters8-K2026-02-26
- Periodic Financial Reports10-K2026-02-06
- Corporate Changes & Voting Matters8-K2026-01-28
- Corporate Changes & Voting Matters8-K2025-12-10
Noticias recientes
- Equal-Weight Strategy RSP Could Outrun SPY if This Macro Shift Continues24/7 Wall St.1d ago
- Podiatrist-approved sneakers and shoes help you put your best foot forward — from $25TheStreet1d ago
- Elevance Health CEO Boudreaux Buys $1 Million in Shares. What Does This Mean For its 2026 Outlook?Motley Fool2d ago
- Leerink Partners Adjusts PT on Elevance Health to $395 From $364, Maintains Market Perform RatingMT Newswires2d ago
- Bernstein Adjusts Price Target on Elevance Health to $488 From $482, Maintains Outperform RatingMT Newswires2d ago
- What's A Strong Quarter Worth When Elevance Health Is Ditching Its Own Markets?Trefis2d ago
- Elevance Health CEO Snaps Up Stock After Post-Earnings SlideBarrons.com2d ago
- Elevance Health Insider Bought Shares Worth $1,002,230, According to a Recent SEC FilingMT Newswires2d ago
Relacionados
Otros activos en esta categoría.
- 8306.TMitsubishi UFJ Financial Group, Inc.3,473 USD-4.30%
- 7203.TToyota Motor Corporation2,899.5 USD-0.33%
- 9984.TSoftBank Group Corp.5,424 USD-9.01%
- 6758.TSony Group Corporation3,470 USD+0.93%
- 6861.TKeyence Corporation70,880 USD-4.28%
- NVDANVIDIA Corporation202.81 USD-2.21%
- AAPLApple Inc.333.74 USD+0.14%
- 0700.HKTencent Holdings Limited477.8 USD+3.51%
Discusión en vivo
Iniciar sesión to join the discussion.
- Aún no hay comentarios. Sé el primero.